Why Women's Experience with Ozempic Is Different

Clinical trials for GLP-1 receptor agonists have historically enrolled populations that are roughly 45 to 55% female. The headline results (A1C reduction, weight loss) are reported as averages across all participants. But hormonal fluctuations, body composition differences, and conditions unique to women (like PCOS and pregnancy) all influence how semaglutide works in practice.

Women typically have a higher percentage of body fat and less lean muscle mass than men at the same BMI. This means the metabolic response to Ozempic can look different. A subgroup analysis of the SUSTAIN trial program showed that women on Ozempic 1 mg lost an average of 11.2 pounds compared to 13.8 pounds for men over 56 weeks, though the percentage of body weight lost was comparable at around 4.5% to 5%.

Hormones also play a role. Estrogen and progesterone influence insulin sensitivity, appetite regulation, and fat storage patterns. These hormonal dynamics shift across the menstrual cycle, during pregnancy, and through menopause, creating a more complex metabolic landscape for women using Ozempic.

Weight Loss Results for Women

Women starting Ozempic can generally expect to lose between 8 and 15 pounds over the first 6 months at the 1 mg maintenance dose. Individual results vary considerably based on starting weight, diet, physical activity, and hormonal status.

What the Research Shows

In the STEP 1 trial (which studied the higher 2.4 mg semaglutide dose used in Wegovy), women made up 74% of participants. The average weight loss for the overall group was 14.9% of body weight over 68 weeks. Women in the trial lost an average of 15.2% of their starting weight, slightly outperforming the overall group.

For the Ozempic-specific doses (0.5 mg and 1 mg), results from the SUSTAIN trials indicate women tend to lose approximately 4% to 6% of their body weight over 30 to 56 weeks. For a woman weighing 200 pounds, that translates to roughly 8 to 12 pounds at the 0.5 mg dose and 10 to 15 pounds at 1 mg.

Factors That Influence Results in Women

• Menstrual cycle phase: Some women retain 2 to 5 pounds of water during the luteal phase (the two weeks before their period). This can mask true fat loss on the scale.
• Thyroid function: Hypothyroidism is 5 to 8 times more common in women than men and can slow weight loss. We recommend thyroid screening before starting Ozempic.
• Sleep quality: Women are 40% more likely to suffer from insomnia than men. Poor sleep raises cortisol and ghrelin levels, both of which promote weight gain and can blunt Ozempic's appetite-suppressing effects.
• Stress and emotional eating: Research from the American Psychological Association shows women are more likely to report eating as a stress-coping mechanism. Ozempic helps by reducing appetite signals, but addressing underlying stress is important for sustained results.

Ozempic and Polycystic Ovary Syndrome (PCOS)

PCOS affects approximately 1 in 10 women of reproductive age and is closely tied to insulin resistance, making GLP-1 receptor agonists a potentially valuable treatment tool. While Ozempic is not FDA-approved for PCOS, a growing body of evidence supports its use in this population.

How Ozempic May Help PCOS

Insulin resistance is a central driver of PCOS. Elevated insulin levels stimulate the ovaries to produce excess androgens (like testosterone), which cause symptoms such as irregular periods, acne, and excess hair growth. By improving insulin sensitivity and promoting weight loss, Ozempic can break this cycle.

A 2023 randomized trial published in the Journal of Clinical Endocrinology and Metabolism studied 60 women with PCOS who received either semaglutide 1 mg or placebo for 24 weeks. The semaglutide group experienced a 12.5% reduction in body weight, a 35% drop in fasting insulin levels, and a 22% reduction in free testosterone. Notably, 40% of previously anovulatory women in the treatment group resumed regular ovulation.

Important Considerations for Women with PCOS

If you have PCOS and are not trying to conceive, this is excellent news. But if you have PCOS and have been relying on anovulation as a form of birth control (common among women who have been told they may have difficulty conceiving), the restored fertility can come as a surprise. We discuss contraception planning with every PCOS patient who starts Ozempic. Ozempic and fertility

Fertility and Pregnancy Considerations

This is perhaps the most critical section of this guide. The intersection of Ozempic and fertility requires careful planning and honest conversation with your provider.

The "Ozempic Baby" Phenomenon

You may have heard about "Ozempic babies" in the news. The term refers to unplanned pregnancies that occur after women start GLP-1 receptor agonists. This happens for two main reasons: weight loss can restore ovulation in women who were not ovulating regularly, and improved insulin sensitivity can normalize reproductive hormones. A 2024 retrospective study from Vanderbilt University Medical Center found that women of reproductive age who started semaglutide had a 45% higher rate of unplanned pregnancy compared to matched controls in the first year of treatment.

Should You Use Ozempic If You Are Trying to Conceive?

Novo Nordisk recommends discontinuing Ozempic at least 2 months before a planned pregnancy. This is based on the drug's long half-life (about 7 days) and the lack of human safety data during pregnancy. Animal studies showed embryotoxicity at high doses, though these doses far exceeded what is used in humans.

That said, some reproductive endocrinologists use semaglutide as a preconception weight loss tool for women with obesity-related infertility, discontinuing it before conception attempts begin. If you are planning a pregnancy in the next 6 to 12 months, talk to your provider about using Ozempic strategically during the preconception period.

Ozempic During Pregnancy and Breastfeeding

Ozempic is classified as a pregnancy risk and should not be used during pregnancy. If you become pregnant while on Ozempic, stop the medication immediately and contact your healthcare provider. There is limited data on semaglutide in breast milk, and Novo Nordisk advises against breastfeeding while taking Ozempic.

Effects on Menstrual Cycles

Many women notice changes in their menstrual cycles after starting Ozempic. While this is not a formally studied endpoint in most clinical trials, patient reports and smaller studies have documented several patterns.

What Women Report

• Shorter or lighter periods: Some women find their periods become shorter, possibly due to improved hormonal balance as insulin resistance decreases.
• Heavier or irregular periods: Other women, especially in the first 2 to 3 months, experience heavier or irregular bleeding. This may be related to rapid hormonal shifts during weight loss.
• Return of periods: Women with PCOS-related amenorrhea (absent periods) sometimes see their cycles return within 2 to 4 months of starting treatment.
• Increased PMS symptoms: A subset of women report worsened premenstrual symptoms, particularly bloating and mood changes, during the first few months.

A 2025 survey published in Obesity Research and Clinical Practice that tracked 312 premenopausal women on semaglutide found that 28% reported menstrual changes in the first 3 months, with most stabilizing by month 6.

If you experience significant or persistent menstrual changes, it is worth discussing with your provider to rule out other causes unrelated to the medication.

Ozempic During Perimenopause and Menopause

Women in perimenopause and menopause face unique metabolic challenges. Declining estrogen levels promote visceral fat accumulation, increase insulin resistance, and raise cardiovascular risk. Ozempic can be particularly effective during this phase of life.

Why Menopause Makes Weight Loss Harder

Estrogen helps maintain insulin sensitivity and influences where the body stores fat. As estrogen declines during perimenopause (typically between ages 45 and 55), women tend to gain an average of 1.5 pounds per year and shift fat storage from the hips and thighs to the abdomen. This visceral fat is more metabolically dangerous and harder to lose through diet and exercise alone.

How Ozempic Helps Menopausal Women

Ozempic addresses several menopause-related metabolic issues simultaneously. It reduces appetite (counteracting the increased hunger driven by hormonal changes), improves insulin sensitivity, and targets visceral fat. A post-hoc analysis of the STEP trials found that women over 50 lost an average of 13.4% of body weight on semaglutide 2.4 mg, comparable to younger participants.

Combining Ozempic with Hormone Replacement Therapy (HRT)

There is no known interaction between Ozempic and hormone replacement therapy. In fact, some providers believe the combination may be complementary: HRT addresses estrogen deficiency while Ozempic targets insulin resistance and weight. If you are on HRT or considering it, your Form Blends provider can help coordinate both treatments.

Ozempic and Birth Control

Because Ozempic slows gastric emptying, there is a theoretical concern that it could reduce the absorption of oral contraceptives. This is one of the most frequently asked questions we receive from women of reproductive age.

What the Data Says

Novo Nordisk studied this directly. In a pharmacokinetic study, semaglutide did not significantly reduce the overall absorption of a combined oral contraceptive pill (ethinyl estradiol/levonorgestrel), though the peak blood levels of the hormones were slightly lower and occurred later. The clinical significance of this delayed absorption is not fully established.

Our Recommendation

We advise women on oral birth control who start Ozempic to consider using a backup contraceptive method (such as condoms) for the first 2 to 3 months. Alternatively, non-oral contraceptives (IUD, implant, patch, ring, or injection) are not affected by gastric emptying changes and may be preferable. If you are relying solely on the pill, discuss this with your provider.

Side Effects Women Report Most

The overall side effect profile of Ozempic is similar between men and women, but certain side effects appear to be reported more frequently by women in post-marketing data and patient surveys.

Nausea

Women report nausea at a slightly higher rate than men. In the SUSTAIN trials, approximately 22% of women experienced nausea compared to 17% of men. This may be related to baseline hormonal differences that affect gut motility. Nausea also tends to be worse during the luteal phase of the menstrual cycle.

Hair Thinning

Hair loss or thinning (telogen effluvium) is a side effect that disproportionately concerns women. It is not caused by Ozempic directly but rather by rapid weight loss. When the body loses weight quickly, it can shift hair follicles from the growth phase to the resting phase. This typically starts 3 to 6 months after significant weight loss begins and resolves on its own within 6 to 12 months. Ensuring adequate protein intake (at least 60 to 80 grams per day) can help minimize this effect.

Gallbladder Issues

Rapid weight loss is a known risk factor for gallstones, and women are already 2 to 3 times more likely than men to develop gallstones due to estrogen's effect on bile composition. The SUSTAIN trials reported gallbladder-related events in approximately 1.5% of Ozempic patients, with a higher proportion being women. Symptoms include upper right abdominal pain, nausea after fatty meals, and occasionally fever.

Fatigue

Some women report increased fatigue, especially during the first month. This may be partly due to reduced caloric intake as appetite decreases. We recommend tracking your daily calories during the first month and ensuring you are eating at least 1,200 calories per day. Going below this threshold can lead to fatigue, nutrient deficiencies, and muscle loss.

Body Composition and Muscle Preservation

One concern with any weight loss treatment is the loss of lean muscle mass along with fat. This is especially important for women, who generally have less muscle mass to begin with and face accelerated muscle loss after menopause.

What Studies Show

In the STEP 1 trial, approximately 40% of the weight lost was lean mass and 60% was fat mass. This ratio is similar to what occurs with calorie-restricted diets alone. However, resistance training can significantly shift this ratio in favor of fat loss. A 2024 study from the University of Alabama at Birmingham found that women on semaglutide who performed resistance training twice per week preserved 85% of their lean mass compared to 62% in the sedentary group.

Our Recommendations

• Aim for 2 to 3 resistance training sessions per week, focusing on compound movements (squats, deadlifts, rows, presses)
• Consume at least 0.7 grams of protein per pound of body weight daily
• Consider supplementing with creatine monohydrate (3 to 5 grams daily), which is safe for women and supports muscle maintenance
• Avoid crash-level calorie restriction; eat enough to fuel your workouts

Mental Health and Body Image

Weight loss medications can intersect with mental health in complex ways, and this deserves an honest conversation. For many women, Ozempic provides a sense of empowerment and relief after years of struggling with weight. But for some, rapid body changes can trigger anxiety, disordered eating patterns, or a complicated relationship with the scale.

In July 2023, the European Medicines Agency (EMA) initiated a review of GLP-1 receptor agonists after reports of suicidal thoughts in a small number of patients. Their review concluded in April 2024 that the available evidence did not support a causal link, but they recommended continued monitoring.

If you have a history of eating disorders, depression, or anxiety, please discuss this openly with your Form Blends provider. We can adjust our monitoring approach, connect you with mental health resources, and ensure the medication is supporting your overall wellbeing, not just the number on the scale.

Getting Started with Ozempic at Form Blends

Our telehealth consultations are designed to address the specific needs of women considering Ozempic. Here is what you can expect:

1. Comprehensive health intake: We ask about menstrual history, reproductive plans, PCOS status, thyroid function, current contraception, and mental health history.
2. Lab review or ordering: We review recent bloodwork or order a panel including A1C, fasting glucose, thyroid panel, lipids, and if relevant, reproductive hormones.
3. Personalized treatment plan: Your provider recommends a medication and dosing strategy tailored to your specific goals and health situation.
4. Ongoing support: Monthly check-ins to adjust dosing, address side effects, and review progress. We monitor for hair changes, menstrual irregularities, and nutritional adequacy.

telehealth weight loss consultation

Frequently Asked Questions

Will Ozempic affect my fertility if I want to get pregnant in the future?

There is no evidence that Ozempic causes long-term fertility damage. In fact, for women with PCOS or obesity-related anovulation, it may temporarily improve fertility by restoring ovulation. The key is to stop the medication at least 2 months before attempting conception.

Is Ozempic safe for women over 60?

Yes, with appropriate monitoring. Women over 60 should pay extra attention to muscle preservation and bone health. Rapid weight loss can accelerate bone density loss in postmenopausal women. Your provider may recommend a DEXA scan and ensure adequate calcium and vitamin D intake.

Can Ozempic help with hormonal belly fat?

The visceral fat that accumulates around the midsection due to hormonal changes (particularly during and after menopause) does respond to Ozempic. Semaglutide has been shown to preferentially reduce visceral fat. In the SUSTAIN trials, MRI substudies demonstrated a 15% reduction in visceral adipose tissue over 40 weeks.

Should I take Ozempic if I have an eating disorder history?

This requires careful evaluation. Ozempic suppresses appetite, which can be therapeutic for binge eating disorder but potentially harmful for someone with a restrictive eating disorder history. An honest conversation with your provider is essential before starting treatment.

Does Ozempic cause face changes ("Ozempic face")?

"Ozempic face" refers to the facial volume loss that can occur with significant weight loss, causing a gaunt or aged appearance. This is more noticeable in women over 40 and those who lose a large amount of weight rapidly. Slower, steadier weight loss and adequate protein intake can minimize this effect. Some patients consult with a dermatologist about dermal fillers if the facial changes are bothersome.

Can I use Ozempic while going through IVF?

Most reproductive endocrinologists recommend stopping Ozempic before starting an IVF cycle. The medication should be discontinued at least 2 months prior. Some fertility specialists use semaglutide in the months leading up to IVF to optimize weight and metabolic health, but it should be stopped before egg retrieval and transfer.

Start Your Personalized Journey

Every woman's experience with Ozempic is shaped by her unique hormonal landscape, health history, and life stage. At Form Blends, our providers take the time to understand these factors and build a treatment plan around you. Book a consultation to learn if Ozempic is the right next step.

Book Your Free Consultation